Skip to main content

Vasoconstrictive Effect of Tenascin-C on Cerebral Arteries in Rats

  • Chapter
  • First Online:
Neurovascular Events After Subarachnoid Hemorrhage

Abstract

Background and purpose: The authors have reported that tenascin-C (TNC), a matricellular protein, is induced after subarachnoid hemorrhage (SAH), associated with cerebral vasospasm. In this study, we examined whether TNC alone causes cerebral vasospasm-like constriction of the intracranial internal carotid arteries (ICAs) in rats, focusing on the p38 mitogen-activated protein kinase (MAPK)-mediated mechanisms.

Methods: First, we injected 10 μg of TNC into the cisterna magna of healthy rats and studied morphologically whether TNC caused constriction of the left ICA at 24–72 h after administration. Second, we examined the effect of SB203580 (a p38 MAPK inhibitor) on the vessel diameter of the left ICA in healthy rats at 24 h. Third, we evaluated the effect of SB203580 on TNC-induced constriction of the left ICA in healthy rats at 24 h.

Results: TNC significantly induced cerebral vasospasm-like angiographic constriction of the left ICAs, which continued at least for 72 h. SB203580 itself had no effect on the diameter of normal ICAs, but abolished the TNC-induced vasoconstrictive effect on the left ICA.

Conclusion: These findings show that TNC causes left ICA constriction via activation of p38 MAPK, resembling post-SAH vasospasm, and suggest the possible involvement of TNC in the pathogenesis of cerebral vasospasm.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kern M, Lam MM, Knuckey NW, Lind CR (2009) Statins may not protect against vasospasm in subarachnoid haemorrhage. J Clin Neurosci 16:527–530

    Article  PubMed  CAS  Google Scholar 

  2. Midwood KS, Hussenet T, Langlois B, Orend G (2011) Advances in tenascin-C biology. Cell Mol Life Sci 68:3175–3199

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  3. Pan YX, Chen KF, Lin YX, Wu W, Zhou XM, Zhang XS, Zhang X, Shi JX (2013) Intracisternal administration of SB203580, a p38 mitogen-activated protein kinase inhibitor, attenuates cerebral vasospasm via inhibition of tumor-necrosis factor-α. J Clin Neurosci 20:726–730

    Article  PubMed  CAS  Google Scholar 

  4. Ruiz C, Huang W, Hegi ME, Lange K, Hamou MF, Fluri E, Oakeley EJ, Chiquet-Ehrismann R, Orend G (2004) Growth promoting signaling by tenascin-C. Cancer Res 64:7377–7385

    Article  PubMed  CAS  Google Scholar 

  5. Shiba M, Suzuki H, Fujimoto M, Shimojo N, Imanaka-Yoshida K, Yoshida T, Kanamaru K, Matsushima S, Taki W (2012) Imatinib mesylate prevents cerebral vasospasm after subarachnoid hemorrhage via inhibiting tenascin-C expression in rats. Neurobiol Dis 46:172–179

    Article  PubMed  CAS  Google Scholar 

  6. Suzuki H, Kanamaru K, Suzuki Y, Aimi Y, Matsubara N, Araki T, Takayasu M, Kinoshita N, Imanaka-Yoshida K, Yoshida T, Taki W (2010) Tenascin-C is induced in cerebral vasospasm after subarachnoid hemorrhage in rats and humans: a pilot study. Neurol Res 32:179–184

    Article  PubMed  CAS  Google Scholar 

  7. Suzuki H, Hasegawa Y, Kanamaru K, Zhang JH (2011) Mitogen-activated protein kinases in cerebral vasospasm after subarachnoid hemorrhage: a review. Acta Neurochir Suppl 110:133–139

    PubMed  Google Scholar 

  8. Taki W, Sakai N, Suzuki H, PRESAT group (2011) Determinants of poor outcome following aneurysmal subarachnoid hemorrhage when both clipping and coiling are available: Prospective Registry of Subarachnoid Aneurysms Treatment (PRESAT) in Japan. World Neurosurg 76:437–445

    Article  PubMed  Google Scholar 

  9. Wang R, Li ZQ, Han X, Li BL, Mi XY, Sun LM, Song M, Han YC, Zhao Y, Wang EH (2010) Integrin β3 and its ligand regulate the expression of uPA through p38 MAPK in breast cancer. APMIS 118:909–917

    Article  PubMed  CAS  Google Scholar 

  10. Yang Y, Dang D, Mogi S, Ramos DM (2004) Tenascin-C deposition requires beta3 integrin and Src. Biochem Biophys Res Commun 322:935–942

    Article  PubMed  CAS  Google Scholar 

  11. Yoshida T, Yoshimura E, Numata H, Sakakura Y, Sakakura T (1999) Involvement of tenascin-C in proliferation and migration of laryngeal carcinoma cells. Virchows Arch 435:496–500

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank Ms. Chiduru Yamamoto (Department of Neurosurgery, Mie University Graduate School of Medicine) for her technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science to Dr. Suzuki.

Conflict of Interest Statement

 We declare that we have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masashi Fujimoto MD, PhD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Fujimoto, M. et al. (2015). Vasoconstrictive Effect of Tenascin-C on Cerebral Arteries in Rats. In: Fandino, J., Marbacher, S., Fathi, AR., Muroi, C., Keller, E. (eds) Neurovascular Events After Subarachnoid Hemorrhage. Acta Neurochirurgica Supplement, vol 120. Springer, Cham. https://doi.org/10.1007/978-3-319-04981-6_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-04981-6_17

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-04980-9

  • Online ISBN: 978-3-319-04981-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics